||||||||||
syndroom van mitochondriale myopathie, cerebellaire ataxie en pigmentretinopathie (aandoening)
syndroom van mitochondriale myopathie, cerebellaire ataxie en pigmentretinopathie
syndroom van mitochondriƫle myopathie, cerebellaire atrofie en pigmentretinopathie
Mitochondrial myopathy, cerebellar ataxia, pigmentary retinopathy syndrome
Mitochondrial myopathy, cerebellar atrophy, pigmentary retinopathy syndrome
A rare mitochondrial myopathy with characteristics of motor developmental delay (in infancy), growth impairment and mostly proximal muscle weakness caused by a muscular dystrophy. Muscle biopsy presents myopathic abnormalities and decreased mitochondrial deoxyribonucleic acid (mtDNA) content. Electromyography (EMG) shows a myopathic process and serum creatine kinase is increased. The disease also has characteristics of early onset non-progressive cerebellar atrophy (particularly cerebellar vermis and hemispheres), corticospinal tract dysfunction, and global or partial cerebral atrophy on brain MRI. Additionally, some patients presented with cognitive deficiencies, skeletal abnormalities, tremors and retinopathy. Caused by biallelic mutations in the MSTO1 gene located on chromosome 1q22 with autosomal recessive inheritance. In a very few cases, the pattern of inheritance is autosomal dominant.
Id1237514002
StatusPrimitive
Occurrencecongenitaal
Associated morphologyatrophia
Finding sitestructuur van cerebellum
SNOMED CT to Orphanet simple map502423
SNOMED CT to ICD-10 extended map
TargetG71.3
RuleTRUE
AdviceALWAYS G71.3 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified